🇺🇸 FDA
Patent

US 11807646

4-hydroxypiperidine derivatives and their use as inhibitors of ubiquitin specific protease 19 (USP19)

granted A61KA61K31/438A61K31/454

Quick answer

US patent 11807646 (4-hydroxypiperidine derivatives and their use as inhibitors of ubiquitin specific protease 19 (USP19)) held by ALMAC DISCOVERY LIMITED expires Mon Nov 02 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
ALMAC DISCOVERY LIMITED
Grant date
Tue Nov 07 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 02 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61K, A61K31/438, A61K31/454, A61K31/4545, A61K31/4725